Global partners announce a new effort – “The Big Catch-up” – to vaccinate millions of children and restore immunization progress lost during the pandemic – World Health Organization April 24, 2023
Moderna and Merck Announce mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, in Combination with KEYTRUDA(R) (Pembrolizumab), Demonstrated Superior Recurrence-Free Survival in Patients with High-Risk Stage III/IV Melano – Moderna Investor Relations April 16, 2023
Moderna and Merck Announce mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, in Combination with KEYTRUDA(R) (Pembrolizumab), Demonstrated Superior Recurrence-Free Survival in Patients with High-Risk Stage III/IV Melano – news.modernatx.com April 16, 2023
McHenry, Waters Announce First Hearing on Silicon Valley Bank and Signature Bank Failures | Financial Services Committee – House Financial Services Committee March 17, 2023
CBS Sports and Warner Bros. Discovery Sports announce 2023 NCAA Division I men’s basketball championship commentator teams – NCAA.com March 7, 2023
Black Knight and Intercontinental Exchange Announce Agreement to Sell Black Knight’s Empower LOS Business to Constellation Software Inc. and Revised Terms of Merger Agreement – Business Wire March 7, 2023
Paradox Interactive and Harebrained Schemes announce turn-based strategy game The Lamplighters League for Xbox Series, PC – Gematsu March 6, 2023
Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination With KEYTRUDA(R) (pembrolizumab), was Granted Breakthrough Therapy Designation by the FDA for Adjuvant Treatment of Patients – Moderna Investor Relations February 22, 2023
NM State men’s basketball team returns to Las Cruces; pair of players announce departure from suspended program – KTSM 9 News February 11, 2023